Pneumonia

Semin Fetal Neonatal Med. 2017 Aug;22(4):206-213. doi: 10.1016/j.siny.2017.03.002. Epub 2017 Mar 24.

Abstract

Neonatal pneumonia may occur in isolation or as one component of a larger infectious process. Bacteria, viruses, fungi, and parasites are all potential causes of neonatal pneumonia, and may be transmitted vertically from the mother or acquired from the postnatal environment. The patient's age at the time of disease onset may help narrow the differential diagnosis, as different pathogens are associated with congenital, early-onset, and late-onset pneumonia. Supportive care and rationally selected antimicrobial therapy are the mainstays of treatment for neonatal pneumonia. The challenges involved in microbiological testing of the lower airways may prevent definitive identification of a causative organism. In this case, secondary data must guide selection of empiric therapy, and the response to treatment must be closely monitored.

Keywords: Immunity; Infection; Multidrug resistance; Pulmonary; TORCH infection; Ventilator-associated pneumonia.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity
  • Combined Modality Therapy / adverse effects
  • Combined Modality Therapy / trends
  • Cross Infection / prevention & control
  • Evidence-Based Medicine*
  • Humans
  • Immunity, Innate
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control
  • Pneumonia / diagnosis*
  • Pneumonia / epidemiology
  • Pneumonia / immunology
  • Pneumonia / therapy
  • Pneumonia, Ventilator-Associated / prevention & control
  • Practice Guidelines as Topic
  • Risk Factors